Pharmaceutical Quality Resources
- Drug Applications and Current Good Manufacturing Practice (CGMP) Regulations
- Generic Drugs: Information for Industry
- Premarket Focused, Quality Related Guidance
- Drug Master Files
- Inactive Ingredient Database
- The following contain lists of CGMP related guidance (i.e. operating a drug manufacturing facility to acceptable standards on an ongoing basis).
- All CDER Guidances
- Report a Product Quality Issue: Identify quality defects in distributed drug products that may present a potential safety threat
- Quality Metrics
Inspections
Inspection of NDA and BLA Applications (REdI Spring 2016): Slides
FDA’s Pre-Approval Inspection (PAI) Program and How to prepare (Fall 2015): Slides
Focus on CGMPs and FDA Inspections: REdI Conference (Summer 2015): Slides
Post approval Changes Related to Drug Product Quality, Manufacturing and Controls(5/12/14): Webinar
Pharmaceutical Product Lifecycle
Application of cGMPs to Drug Product Quality Microbiology Laboratory Tests and Manufacturing Process Validation (REdI Spring 2016): Slides/Recording
Risk and Team-based Integrated Quality Assessment in the Office of Pharmaceutical Quality (REdI Spring 2016): Slides/Recording
FDA’s Office of Pharmaceutical Quality (4/4/16): CDER SBIA Chronicles
Pharmaceutical Quality Symposium: REdI Conference (July 2016): Slides
FDA Drug Quality Regulation: Current Topics (REdI Fall 2014): Slides
FDA Drug Quality Regulation: Current Topics (REdl Spring 2014): Slides
New Drug Quality (9/17/12): CDER SBIA Chronicles